Short Courses - Applied Pharmaceutical Analysis - India

“The theme of this year, I felt had the correct balance of large & small molecule, reg and non-reg as well as Bioanalysis, Biotransformation and Biomarkers.” -APA Attendee

“I was particularly impressed by the combination of biotrans and bioanalytical subject matter - this link is crucial to my mind.” -APA Attendee

“Keep going on the combination of ADME and bioanalytical sciences for large and small molecules. I was impressed with the conference content this year.” -APA Attendee

“Liked the overall mix with more large molecule presentaions and still having biotransformation.” -APA Attendee

“Continue to have FDA updates what it is looking for on the regulated bioanalysis field.” -APA Attendee

“Appreciate the multiple speakers from the FDA. Very nice to see more than one representative from the FDA.” -APA Attendee

“I thought the FDA participation was well suited to the meeting and an important addition.” -APA Attendee

“FDA participation has always been quality including this year.” -APA Attendee

“Boston society staffs are very friendly and helpful.” -APA Attendee

“The APA conference is excellent, and I am hearing from colleagues that it is the conference of choice. It has gained popularity due to the high quality of speakers and topics that are presented each year.” -APA Attendee

“The content all hinges on the quality of speakers selected and the dispersion of topics. Really liked the broad representation of FDA speakers facilitated by the meeting proximity to their offices. Having that opportunity for direct scientific and policy discussion is a major selling point for this meeting.” -APA Attendee

“I was very impressed with my first APA!” -APA Attendee

“I just want to say that it is really impressive that you managed to get so many FDA officals to speak at the meeting.” -APA Attendee

“As I am a biotransformation person and leader of MIST activities in my company, this session was extremely valuable. Good spread of speakers over Pharma.” -APA Attendee

Short Courses run concurrently and are all day sessions. (Lunch included)

Short Course 1: Immunogenicity (8:00 am - 5:00 pm)

SESSION	SPEAKER	COMPANY	TIME
Introduction to Immunogenicity
ATA Screening Assays
Risk Assessment

Short Course 2: Advancement in Met-ID (8:00 am - 5:00 pm)

SESSION	SPEAKER	COMPANY	TIME
High-Resolution Mass Spec	Ramaswamy Iyer	Bristol-Myers Squibb
NMR	Gregory Walker	Pfizer